Shenzhen Chipscreen Biosciences Hits Day High with 4.6% Surge

Shenzhen Chipscreen Biosciences Co., Ltd. has experienced a notable increase of 4.6% on March 27, 2026, reaching an intraday high of CNY 30.33. This performance stands out against the backdrop of the China Shanghai Composite, which only gained 0.63% on the same day. Over the past week, Shenzhen Chipscreen has shown a positive trend with a 2.39% increase, contrasting with a decline of 1.09% in the broader market. Despite a challenging month where the stock has decreased by 7.98%, its year-to-date performance remains positive at 2.67%. Over the past year, Shenzhen Chipscreen has delivered an impressive return of 60.0%, significantly outperforming the China Shanghai Composite's 16.01%. The company operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 13,091 million. While the stock has shown resilience in recent performance metrics, it is important to note that the company has faced challenges, including a low return on capital employed and a negative net worth. Nonetheless, recent financial results indicate a strong growth trajectory in operating cash flow and net profit, suggesting potential for recovery in its operational efficiency.